World-class
Scientific Advisory

Work with Richmond Pharmacology and trust your experience will be personal and truly strategic.

Dilshat Djumanov MPhil, PhD
Director of Data Science

Dilshat has an in depth knowledge of data management and data analysis for adaptive clinical trials and QTc studies. Dilshat has a background in IT and demonstrable knowledge of process automation and improvement.

Having worked at Richmond Pharmacology for 14 years, he has led pioneering software development projects which have ensured Richmond Pharmacology’s data management and other processes are efficient, transparent and fast.

Dilshat’s experience is backed by his academic achievements, including a MSc in Computer Sciences, a MPhil in Medical Engineering and a PhD in Computational Fluid Dynamics.  

Back to experts

Latest news

Upcoming Event

EUFEMED, 3rd Annual Conference, 28-30 April 2021

28-30 April 2021
Dr Jorg Taubel will co-chair a session on day one, which explores how technology has reduced the risks of pandemic effects on Phase I and II trial performance.
View event

Richmond Pharmacology listed in the Alantra Pharma Fast 50

July 13, 2021
Richmond has been included in a top 50 list of the UK’s fastest-growing, privately-owned pharmaceutical businesses. 
Read more

Richmond Pharmacology listed in the J.P. Morgan Top 200 Female Powered Businesses

June 29, 2021
J.P. Morgan has identified Richmond Pharmacology as a high-growth female-powered business in its annual 'Top 200 Female Powered Businesses' list 2021.
Read more

CRISPR-Cas9 in-vivo gene editing shows reduction in TTR after a single dose

June 29, 2021
Data produced through Intellia Therapeutic’s NTLA-2001 FIH clinical trial, conducted at Richmond Pharmacology, indicates a reduction in the faulty TTR protein after a single infusion. Results were presented by Professor Julian Gillmore at this year’s Peripheral Nerve Society Annual Meeting.
Read more